 |
|
|
|
|
|
|
|
|
|
|
|
1 to 12 of 12 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Basun H, Ingelsson M, Lannfelt L. on NEWS: NIH Director Announces $100M Prevention Trial of Genentech Antibody, It is great news that Genentech and the NIH are taking the bold initiative to start a prevention... 30 May 2012.
|
|
|
 |
|
|
Ingelsson M. on PAPER: Colla E. et al., 2012, This is an interesting paper, indicating a marked elevation in the levels of various truncated... 19 Mar 2012.
|
|
|
|
|
|
Ingelsson M, Lannfelt L. on PAPER: Tokuda T. et al., 2010, The potential of CSF α-synuclein as a biomarker for Parkinson’s disease has been investigated by... 29 Oct 2010.
|
|
|
|
|
|
Ingelsson M. on NEWS: Excess α-Synuclein Sends Synapses Sputtering, The work by Scott and colleagues is of great interest as it is trying to pinpoint the molecular... 18 Jun 2010.
|
|
|
|
|
|
Ingelsson M. on PAPER: Salloway S. et al., 2009, Although the outcome maybe wasn’t as good as had been hoped for, the Phase 2 study on... 30 Dec 2009.
|
|
|
|
|
|
Ingelsson M. on PAPER: Kang JE. et al., 2009, In this work from Dave Holtzman’s lab, the influence of the sleep-wake cycle on Aβ metabolism... 30 Dec 2009.
|
|
|
|
|
|
Ingelsson M. on PAPER: Koffie RM. et al., 2009, Several papers in 2009 have explored the physiological consequences of Aβ oligomers in Alzheimer... 30 Dec 2009.
|
|
|
|
|
|
Ingelsson M. on PAPER: Gitler AD. et al., 2009, In this work, Susan Lindquist and colleagues from the Whitehead Institute reported a functional... 30 Dec 2009.
|
|
|
|
|
|
Ingelsson M. on PAPER: Ibáñez P. et al., 2009, It has been a good 10 years since the first disease-causing mutation in the α-synuclein gene... 23 Jan 2009.
|
|
|
|
|
|
Ingelsson M. on SITE POLL: Are you in favor of ICAD going annual?, I agree with Dr. Windisch. The conference schedule for AD and PD researchers is tight as it is... 11 Nov 2008.
|
|
|
|
|
|
Bergstrom J, Ingelsson M. on NEWS: Guilt by Association?—Aβ, α-Synuclein Make Mixed Oligomers, Already back in the early 1990s, a research team led by Dr. Saitoh co-purified a novel molecule... 24 Sep 2008.
|
|
|
|
|
|
Ingelsson M, Lannfelt L. on NEWS: Looking outside the Brain for Early Signs of AD, Expression arrays in Alzheimer disease mutation-carriers: a common biochemical... 6 Oct 2005.
|
|
|
|
|
|
|
1 to 12 of 12 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
See our latest Webinar: 
